{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:17:26Z","timestamp":1792297046565,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS073712"],"award-info":[{"award-number":["NS073712"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","award":["6483"],"award-info":[{"award-number":["6483"]}],"id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM088129"],"award-info":[{"award-number":["GM088129"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI053831"],"award-info":[{"award-number":["AI053831"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL007676"],"award-info":[{"award-number":["HL007676"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR069960"],"award-info":[{"award-number":["AR069960"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HG006348"],"award-info":[{"award-number":["HG006348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR024574"],"award-info":[{"award-number":["RR024574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA125123"],"award-info":[{"award-number":["CA125123"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-018-1783-9","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T03:44:40Z","timestamp":1546832680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis"],"prefix":"10.1186","volume":"21","author":[{"given":"Mark R.","family":"Tanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satendra S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresina","family":"Laragione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9rcio S.","family":"Gulko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-5874","authenticated-orcid":false,"given":"Christine","family":"Beeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"issue":"Suppl 1","key":"1783_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2412","volume":"10","author":"A Cope","year":"2008","unstructured":"Cope A. T cells in rheumatoid arthritis. Arthritis Res Ther. 2008;10(Suppl 1):S1.","journal-title":"Arthritis Res Ther"},{"issue":"(5 Suppl 46)","key":"1783_CR2","first-page":"S4","volume":"25","author":"A Cope","year":"2007","unstructured":"Cope A, Schulze-Koops H, Aringer M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol. 2007;25((5 Suppl 46)):S4\u201311.","journal-title":"Clin Exp Rheumatol"},{"key":"1783_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrrheum.2015.8","volume":"11","author":"J Smolen","year":"2015","unstructured":"Smolen J, Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities, and challenges. Nat Rev Rheumatol. 2015;11:276\u201389.","journal-title":"Nat Rev Rheumatol"},{"key":"1783_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/157339711794474620","volume":"7","author":"F Keyser","year":"2011","unstructured":"Keyser F. Choice of biologic therapy for patients with rheumatoid arthritis: the infection perspective. Curr Rheumatol Rev. 2011;7:77\u201387.","journal-title":"Curr Rheumatol Rev"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.0300-9475.2004.01464.x","volume":"60","author":"A Fasth","year":"2004","unstructured":"Fasth A, Cao D, van Vollenhoven R, Trollmo C, Malmstrom V. CD28nullCD4+ T cells \u2013 characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand J Immunol. 2004;60:199\u2013208.","journal-title":"Scand J Immunol"},{"issue":"46","key":"1783_CR6","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton C, Wulff H, Standifer N, Azam P, Mullen K, Pennington M, Kolski-Andreaco A, Wei E, Grino A, Counts D, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A. 2006;103(46):17414\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1783_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.toxicon.2011.07.016","volume":"59","author":"V Chi","year":"2012","unstructured":"Chi V, Pennington M, Norton R, Tarcha E, Londono L, Sims-Fahey B, Upadhyay S, Lakey J, Iadonato S, Wulff H, et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 2012;59:529\u201346.","journal-title":"Toxicon"},{"key":"1783_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI16921","volume":"111","author":"H Wulff","year":"2003","unstructured":"Wulff H, Calabresi P, Allie R, Yun S, Pennington M, Beeton C, Chandy K. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest. 2003;111:1703\u201313.","journal-title":"J Clin Invest"},{"key":"1783_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.112.191890","volume":"342","author":"E Tarcha","year":"2012","unstructured":"Tarcha E, Chi V, Munoz-Elias E, Bailey D, Londono L, Upadhyay S, Norton K, Banks A, Tjong I, Nguyen H, et al. Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther. 2012;342:642\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"1783_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.immuni.2008.07.015","volume":"29","author":"M Matheu","year":"2008","unstructured":"Matheu M, Beeton C, Garcia A, Chi V, Pangaraju S, Safrina O, Monaghan K, Uemura M, Li D, Pal S, et al. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity. 2008;29:602\u201314.","journal-title":"Immunity"},{"key":"1783_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","volume":"180","author":"M Tanner","year":"2017","unstructured":"Tanner M, Tajhya R, Huq R, Gehrmann E, Rodarte K, Atik M, Norton R, Pennington M, Beeton C. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. Clin Immunol. 2017;180:45\u201357.","journal-title":"Clin Immunol"},{"key":"1783_CR12","doi-asserted-by":"publisher","first-page":"e0180762","DOI":"10.1371\/journal.pone.0180762","volume":"12","author":"E Tarcha","year":"2017","unstructured":"Tarcha E, Olsen C, Probst P, Peckham D, Munoz-Elias E, Kruger J, Iadonato S. Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial. PLoS One. 2017;12:e0180762.","journal-title":"PLoS One"},{"key":"1783_CR13","unstructured":"Munoz-Elias E, Peckham D, Norton K, Duculan J, Cueto I, Li X, Qin J, Lustig K, Tarcha E, Odegard J, et al. Dalazatide (ShK-186), a first-in-class blocker of Kv1.3 potassium channel on effector memory T cells: safety, tolerability and proof of concept of immunomodulation in patients with active plaque psoriasis [abstract]. Arthritis Rheumatol. 2015;67(suppl 10)."},{"key":"1783_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini N, Firestein G. Dualtiy of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24\u201333.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1783_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein G. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"issue":"8","key":"1783_CR16","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1096\/fj.201601097R","volume":"31","author":"M Tanner","year":"2017","unstructured":"Tanner M, Pennington M, Laragione T, Gulko P, Beeton C. KCa1.1 channels regulate \u03b21 integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytes. FASEB J. 2017;31(8):3309\u201320.","journal-title":"FASEB J"},{"issue":"1","key":"1783_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/art.38883","volume":"67","author":"M Tanner","year":"2015","unstructured":"Tanner M, Hu X, Huq R, Tajhya R, Sun L, Khan F, Laragione T, Horrigan F, Gulko P, Beeton C. KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis. Arthritis Rheumatol. 2015;67(1):96\u2013106.","journal-title":"Arthritis Rheumatol"},{"key":"1783_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13075-016-1003-4","volume":"18","author":"Z Peth\u0151","year":"2016","unstructured":"Peth\u0151 Z, Tanner M, Tajhya R, Huq R, Laragione T, Panyi G, Gulko P, Beeton C. Different expression of \u03b2 subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes. Arthritis Res Ther. 2016;18:103.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1783_CR19","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1074\/jbc.M111.312264","volume":"287","author":"X Hu","year":"2012","unstructured":"Hu X, Laragione T, Sun L, Koshy S, Jones K, Ismailov I, Yotnda P, Horrigan F, Gulko P, Beeton C. KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis. J Biol Chem. 2012;287(6):4014\u201322.","journal-title":"J Biol Chem"},{"key":"1783_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14728222.2017.1398234","volume":"21","author":"C Beeton","year":"2017","unstructured":"Beeton C. KCa1.1 channels as therapeutic targets for rheumatoid arthritis. Expert Opin Ther Targets. 2017;21:1077\u201381.","journal-title":"Expert Opin Ther Targets"},{"key":"1783_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/jpet.117.245118","volume":"365","author":"M Tanner","year":"2018","unstructured":"Tanner M, Pennington M, Chamberlain B, Huq R, Gehrmann E, Laragione T, Gulko P, Beeton C. Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis. J Pharmacol Exp Ther. 2018;365:227\u201336.","journal-title":"J Pharmacol Exp Ther"},{"key":"1783_CR22","first-page":"268","volume":"82","author":"A Boots","year":"1994","unstructured":"Boots A, Wimmers-Bertens A, Rijnders A. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology. 1994;82:268\u201374.","journal-title":"Immunology"},{"key":"1783_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/art.1780390117","volume":"39","author":"C Tsai","year":"1996","unstructured":"Tsai C, Diaz LJ, Singer N, Li L, Kirsch A, Mitra R, Nickoloff B, Crofford L, Fox D. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 1996;39:125\u201336.","journal-title":"Arthritis Rheum"},{"key":"1783_CR24","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.4049\/jimmunol.180.5.2989","volume":"180","author":"C Tran","year":"2008","unstructured":"Tran C, Thacker S, Louie D, Oliver J, White P, Endres J, Urguhart A, Chung K, Fox D. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol. 2008;180:2989\u201398.","journal-title":"J Immunol"},{"key":"1783_CR25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2353\/ajpath.2007.070004","volume":"171","author":"C Tran","year":"2007","unstructured":"Tran C, Lundy S, White P, Endres J, Motyl C, Gupta R, Wilke C, Shelden E, Chung K, Urguhart A, et al. Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-\u03b1 on cytokine-activated T cells. Am J Pathol. 2007;171:1588\u201398.","journal-title":"Am J Pathol"},{"key":"1783_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/art.22573","volume":"56","author":"C Tran","year":"2007","unstructured":"Tran C, Davis M, Tesmer L, Endres J, Motyl C, Smuda C, Somers E, Chung K, Urguhart A, Lundy S, et al. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum. 2007;56:1497\u2013506.","journal-title":"Arthritis Rheum"},{"key":"1783_CR27","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.4049\/jimmunol.164.10.5055","volume":"164","author":"C Cho","year":"2000","unstructured":"Cho C, Cho M, Min S, Kim W, Min D, Lee S, Park S, Choe J, Kim H. CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor. J Immunol. 2000;164:5055\u201361.","journal-title":"J Immunol"},{"key":"1783_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2011-200867","volume":"71","author":"A Hot","year":"2012","unstructured":"Hot A, Zrioual S, Lenief V, Miossec P. IL-17 and tumour necrosis factor \u03b1 combination induces a HIF-1\u03b1-dependent invasive phenotype in synoviocytes. Ann Rheum Dis. 2012;71:1393\u2013401.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"1783_CR29","doi-asserted-by":"publisher","first-page":"A48","DOI":"10.1136\/annrheumdis-2011-201235.14","volume":"71","author":"T Karonitsch","year":"2012","unstructured":"Karonitsch T, Dalwigk K, Byrne R, Niedereiter B, Cetin E, Wanivenhaus A, Scheinecker C, Smolen J, Kiener H. IFN-\u03b3 promotes the invasive behavior of fibroblast-like synoviocytes [abstract]. Ann Rheum Dis. 2012;71(Suppl 1):A48.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"1783_CR30","doi-asserted-by":"publisher","first-page":"A63","DOI":"10.1136\/ard.2010.129650k","volume":"69","author":"T Karonitsch","year":"2010","unstructured":"Karonitsch T, Dalwigk K, Byrne R, Niedereiter B, Cetin E, Wanivenhaus A, Scheinecker C, Smolen J, Kiener H. IFN-\u03b3 promotes fibroblast-like synoviocytes motility [abstract]. Ann Rheum Dis. 2010;69(Suppl 2):A63.","journal-title":"Ann Rheum Dis"},{"key":"1783_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/187152811797200641","volume":"10","author":"C Beeton","year":"2011","unstructured":"Beeton C, Pennington M, Norton R. Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases. Inflamm Allergy Drug Targets. 2011;10:313\u201321.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"1783_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2741\/4581","volume":"23","author":"M Tanner","year":"2018","unstructured":"Tanner M, Beeton C. Differences in ion channel phenotype and function between humans and animal models. Front Biosci. 2018;23:43\u201364.","journal-title":"Front Biosci"},{"key":"1783_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/prot.10341","volume":"52","author":"Y Gao","year":"2003","unstructured":"Gao Y, Garcia M. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels. Proteins. 2003;52:146\u201354.","journal-title":"Proteins"},{"key":"1783_CR34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1161\/ATVBAHA.111.242727","volume":"32","author":"P Cidad","year":"2012","unstructured":"Cidad P, Jimenez-Perez L, Garcia-Arribas D, Miguel-Velado E, Tajada S, Ruiz-McDavitt C, Lopez-Lopez J, Perez-Garcia M. Kv1.3 channels can modulate cell proliferation during phenotypic switch by an ion-flux independent mechanism. Arterioscler Thromb Vasc Biol. 2012;32:1299\u2013307.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"69","key":"1783_CR35","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"2010","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C, Birnbaum N, Burmester G, Bykerk V, Cohen M, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;2010(69):1580\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"9\u201310","key":"1783_CR36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2119\/molmed.2010.00049","volume":"16","author":"T Laragione","year":"2010","unstructured":"Laragione T, Gulko P. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med. 2010;16(9\u201310):352\u20138.","journal-title":"Mol Med"},{"key":"1783_CR37","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/art.23610","volume":"58","author":"T Laragione","year":"2008","unstructured":"Laragione T, Brenner M, Mello A, Symons M, Gulko P. The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts. Arthritis Rheum. 2008;58:2296\u2013306.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1783_CR38","first-page":"1227","volume":"45","author":"S Grissmer","year":"1994","unstructured":"Grissmer S, Nguyen A, Aiyar J, Hanson D, Mather R, Gutman G, Karmilowicz M, Auperin D, Chandy K. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol. 1994;45(6):1227\u201334.","journal-title":"Mol Pharmacol"},{"key":"1783_CR39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.166.5.1205","volume":"166","author":"T Ruers","year":"1987","unstructured":"Ruers T, Buurman W, van Boxtel C, van der Linden C, Kootstra G. Immunohistological observations in rat kidney allografts after local steroid administration. J Exp Med. 1987;166:1205\u201320.","journal-title":"J Exp Med"},{"key":"1783_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/10567","volume":"5","author":"A Fl\u00fcgel","year":"1999","unstructured":"Fl\u00fcgel A, Willem M, Berkowicz T, Wekerle H. Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med. 1999;5:843\u20137.","journal-title":"Nat Med"},{"key":"1783_CR41","first-page":"325","volume":"8","author":"C Beeton","year":"2007","unstructured":"Beeton C, Chandy K. Induction and monitoring of adoptive delayed-type hypersensitivity in rats. J Vis Exp. 2007;8:325.","journal-title":"J Vis Exp"},{"key":"1783_CR42","doi-asserted-by":"publisher","first-page":"33808","DOI":"10.1038\/srep33808","volume":"6","author":"R Huq","year":"2016","unstructured":"Huq R, Samuel E, Sikkema W, Nilewski L, Lee T, Tanner M, Khan F, Porter P, Tajhya R, Patel R, et al. Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation. Sci Rep. 2016;6:33808.","journal-title":"Sci Rep"},{"key":"1783_CR43","doi-asserted-by":"publisher","first-page":"e76740","DOI":"10.1371\/journal.pone.0076740","volume":"8","author":"S Koshy","year":"2013","unstructured":"Koshy S, Wu D, Hu X, Tajhya R, Huq R, Khan F, Pennington M, Wulff H, Yotnda P, Beeton C. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. PLoS One. 2013;8:e76740.","journal-title":"PLoS One"},{"key":"1783_CR44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.149.1.309","volume":"149","author":"M Griffiths","year":"1992","unstructured":"Griffiths M, Cremer M, Harper D, McCall S, Cannon G. Immunogenetics of collagen-induced arthritis in rats: both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens. J Immunol. 1992;149:309\u201316.","journal-title":"J Immunol"},{"key":"1783_CR45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/art.20782","volume":"52","author":"M Brenner","year":"2005","unstructured":"Brenner M, Meng H, Yarlett N, Griffiths M, Remmers E, Wilder R, Gulko P. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 2005;52:322\u201332.","journal-title":"Arthritis Rheum"},{"key":"1783_CR46","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1002\/art.30573","volume":"63","author":"T Laragione","year":"2011","unstructured":"Laragione T, Brenner M, Sherry B, Gulko P. CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis. Arthritis Rheum. 2011;63:3274\u201383.","journal-title":"Arthritis Rheum"},{"key":"1783_CR47","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.4049\/jimmunol.167.9.5381","volume":"167","author":"T Nanki","year":"2001","unstructured":"Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol. 2001;167:5381\u20135.","journal-title":"J Immunol"},{"key":"1783_CR48","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/art.21140","volume":"52","author":"H Sawai","year":"2005","unstructured":"Sawai H, Park YW, Roberson J, Imai T, Goronzy J, Weyand C. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2005;52:1392\u2013401.","journal-title":"Arthritis Rheum"},{"key":"1783_CR49","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/art.38263","volume":"66","author":"Y Toyoda","year":"2014","unstructured":"Toyoda Y, Tabata S, Kishi J, Kuramoto T, Mitsuhashi A, Saijo A, Kawano H, Goto H, Aono Y, Hanibuchi M, et al. Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2014;66:560\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"1783_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev-biophys-042910-155238","volume":"41","author":"M Dustin","year":"2012","unstructured":"Dustin M, Groves J. Receptor signaling clusters in the immune synapse. Annu Rev Biophys. 2012;41:543\u201356.","journal-title":"Annu Rev Biophys"},{"key":"1783_CR51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.immunol.19.1.375","volume":"19","author":"S Bromley","year":"2001","unstructured":"Bromley S, Burack W, Johnson K, Somersalo K, Sims T, Sumen C, Davis M, Shaw A, Allen P, Dustin M. The immunological synapse. Annu Rev Immunol. 2001;19:375\u201396.","journal-title":"Annu Rev Immunol"},{"key":"1783_CR52","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1074\/jbc.M113.517037","volume":"289","author":"S Koshy","year":"2014","unstructured":"Koshy S, Huq R, Tanner M, Atik M, Porter P, Khan F, Pennington M, Hanania N, Corry D, Beeton C. Blocking Kv1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014;289:12623\u201332.","journal-title":"J Biol Chem"},{"key":"1783_CR53","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1172\/JCI114908","volume":"86","author":"J Alvaro-Gracia","year":"1990","unstructured":"Alvaro-Gracia J, Zvaifler N, Firestein G. Cytokines in chronic inflammatory arthritis: V. Mutual antagonism between interferon-\u03b3 and tumor necrosis factor-\u03b1 on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest. 1990;86:1790\u20138.","journal-title":"J Clin Invest"},{"key":"1783_CR54","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","volume":"47","author":"M Hashizume","year":"2008","unstructured":"Hashizume M, Hayakawa N, Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-\u03b1 and IL-17. Rheumatology (Oxford). 2008;47:1635\u201340.","journal-title":"Rheumatology (Oxford)"},{"key":"1783_CR55","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/ar2960","volume":"12","author":"C Page","year":"2010","unstructured":"Page C, Smale S, Carty S, Amos N, Lauder S, Goodfellow R, Richards P, Jones S, Topley N, Williams A. Interferon-\u03b3 inhibits interleukin-1\u03b2-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis. Arthritis Res Ther. 2010;12:R49.","journal-title":"Arthritis Res Ther"},{"key":"1783_CR56","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","volume":"158","author":"K Vermeire","year":"1997","unstructured":"Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-\u03b3 receptor-deficient mice. J Immunol. 1997;158:5507\u201313.","journal-title":"J Immunol"},{"key":"1783_CR57","doi-asserted-by":"publisher","first-page":"e60900","DOI":"10.1371\/journal.pone.0060900","volume":"8","author":"J Lee","year":"2013","unstructured":"Lee J, Lee J, Park M, Lim M, Park E, Kim E, Yang E, Lee S, Jhun J, Park S, et al. Interferon \u03b3 suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase. PLoS One. 2013;8:e60900.","journal-title":"PLoS One"},{"key":"1783_CR58","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/anr.1780320805","volume":"32","author":"G Cannon","year":"1989","unstructured":"Cannon G, Pincus S, Emkey R, Denes A, Cohen S, Wolfe F, Saway P, Jaffer A, Weaver A, Crogen L, et al. Double-blind trial of recombinant \u03b3-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 1989;32:964\u201373.","journal-title":"Arthritis Rheum"},{"key":"1783_CR59","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/ard.51.9.1039","volume":"51","author":"K Machold","year":"1992","unstructured":"Machold K, Neumann K, Smolen J. Recombinant human interferon \u03b3 in the treatment of rheumatoid arthritis: double blind placebo controlled study. Ann Rheum Dis. 1992;51:1039\u201343.","journal-title":"Ann Rheum Dis"},{"key":"1783_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/art.1780400110","volume":"40","author":"E Veys","year":"1997","unstructured":"Veys E, Menkes C, Emery P. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-\u03b3 versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 1997;40:62\u20138.","journal-title":"Arthritis Rheum"},{"key":"1783_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/rheumatology\/35.1.24","volume":"35","author":"R Dolhain","year":"1996","unstructured":"Dolhain R, ter Haar N, Hoefakker S, Tak P, de Ley M, Claassen E, Breedveld F, Miltenburg A. Increased expression of interferon (IFN)-\u03b3 together with IFN-\u03b3 receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis. Br J Rheumatol. 1996;35:24\u201332.","journal-title":"Br J Rheumatol"},{"key":"1783_CR62","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1128\/MCB.14.3.1657","volume":"14","author":"J Yuan","year":"1994","unstructured":"Yuan J, Wegenka U, Lutticken C, Buschmann J, Decker T, Schindler C, Heinrich P, Horn F. The signalling pathways of interleukin-6 and \u03b3 interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol. 1994;14:1657\u201368.","journal-title":"Mol Cell Biol"},{"key":"1783_CR63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/14397595.2016.1213481","volume":"27","author":"T Nanki","year":"2017","unstructured":"Nanki T, Imai T, Kawai S. Fractalkine\/CXCL1 in rheumatoid arthritis. Mod Rheumatol. 2017;27:392\u20137.","journal-title":"Mod Rheumatol"},{"key":"1783_CR64","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.4049\/jimmunol.173.11.7010","volume":"173","author":"T Nanki","year":"2004","unstructured":"Nanki T, Urasaki Y, Imai T, Nishimura M, Muramoto K, Kubota T, Miyasaka N. Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J Immunol. 2004;173:7010\u20136.","journal-title":"J Immunol"},{"key":"1783_CR65","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.molimm.2012.06.006","volume":"52","author":"M Pavkova Goldbergova","year":"2012","unstructured":"Pavkova Goldbergova M, Lipkova J, Pavek N, Gatterova J, Vasku A, Soucek M, Nemec P. RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis. Mol Immunol. 2012;52:273\u20138.","journal-title":"Mol Immunol"},{"key":"1783_CR66","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/art.21033","volume":"52","author":"S Shahrara","year":"2005","unstructured":"Shahrara S, Proudfoot A, Woods J, Ruth J, Amin M, Park C, Haas C, Pope R, Haines G, Zha Y, et al. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum. 2005;52:1907\u201319.","journal-title":"Arthritis Rheum"},{"key":"1783_CR67","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/cei.12372","volume":"177","author":"G Tian","year":"2014","unstructured":"Tian G, Liang J, Wang Z, Zhou D. Emerging role of leptin in rheumatoid arthritis. Clin Exp Immunol. 2014;177:557\u201370.","journal-title":"Clin Exp Immunol"},{"key":"1783_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.autrev.2012.07.011","volume":"12","author":"H Carvalheiro","year":"2013","unstructured":"Carvalheiro H, da Silva J, Souto-Carneiro M. Potential roles of CD8+ T cells in rheumatoid arthritis. Autoimmun Rev. 2013;12:401\u20139.","journal-title":"Autoimmun Rev"},{"key":"1783_CR69","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/art.21118","volume":"52","author":"T Tolboom","year":"2005","unstructured":"Tolboom T, van der Helm-Van Mil A, Nelissen R, Breedveld F, Toes R, Huizinga T. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 2005;52:1999\u20132002.","journal-title":"Arthritis Rheum"},{"key":"1783_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.clim.2015.04.001","volume":"158","author":"T Laragione","year":"2015","unstructured":"Laragione T, Cheng K, Tanner M, He M, Beeton C, Al-Abed Y, Gulko P. The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion. Clin Immunol. 2015;158:183\u201392.","journal-title":"Clin Immunol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1783-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:32:49Z","timestamp":1694543569000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1783-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1783-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"3 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments involving the use of rats were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine. De-identified human FLS were isolated by PSG\u2019s group after patients provided written consent for their tissues to be studied, as approved by the Institutional Review Board at the Feinstein Institute for Medical Research. Baylor College of Medicine\u2019s Institutional Review Board determined that the study of these cells did not constitute human research, because the samples were de-identified.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CB and MWP are inventors on the patent for ShK-186\/dalazatide. CB and MWP are cofounders of Airmid, Inc., and sit on its board of directors. CB and MWP are investors in Kineta, Inc. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"6"}}